NovaBridge Biosciences (NBP) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NBPNovaBridge BiosciencesFollow NBP — free
—
Price chart with a free account
- Market cap
- 365.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Apr, in 163 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 47.3% | — | — | — | — | |
| Operating margin | — | — | — | -11395.1% | — | — | — | |
| Net margin | -4840.1% | 30.5% | -2648.7% | -32868.5% | — | — | — | |
| FCF margin | -2934.2% | 27.6% | -1139.5% | -11528.6% | — | — | — |
USD millions · SEC XBRL
Every figure on this page comes from NovaBridge Biosciences's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.